METHYLPREDNISOLONE | N011153 | PFIZER INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Jubilant Generics Limited FDA-2017-P-2129 Jubilant Generics Limited filed this citizen petition pursuant to section 505(j)(2)(c) of the Federal Food, Drug and Cosmetic Act requesting that the FDA determine Methylprednisolone Tablets at strengths of 12 mg, 20 mg, and 28 mg are suitable for submission as an Abbreviated New Drug Application, w | Other | 2017-04-05 | Open | Jubilant Generics Limited |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.